ATE451916T1 - Ophthalmische pharmazeutische zusammensetzungen auf basis von aminosäuren und natriumhyaluronat - Google Patents

Ophthalmische pharmazeutische zusammensetzungen auf basis von aminosäuren und natriumhyaluronat

Info

Publication number: ATE451916T1
Authority: AT; Austria
Prior art keywords: amino acids; pharmaceutical compositions; sodium hyaluronate; compositions based; ophthalmic pharmaceutical
Prior art date: 2005-10-26

Application number

AT06806304T

Other languages

English (en)

Inventor

Franco Conti

Original Assignee

Solartium Entpr Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-10-26

Filing date

2006-10-16

Publication date

2010-01-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37561156&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE451916(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-10-16 Application filed by Solartium Entpr Ltd filed Critical Solartium Entpr Ltd

2010-01-15 Application granted granted Critical

2010-01-15 Publication of ATE451916T1 publication Critical patent/ATE451916T1/de

Links

229920002385 Sodium hyaluronate Polymers 0.000 title abstract 2
150000001413 amino acids Chemical class 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title abstract 2
229940010747 sodium hyaluronate Drugs 0.000 title abstract 2
YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 title abstract 2
230000029663 wound healing Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Dermatology (AREA)
Chemical Kinetics & Catalysis (AREA)
Ophthalmology & Optometry (AREA)
Molecular Biology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT06806304T 2005-10-26 2006-10-16 Ophthalmische pharmazeutische zusammensetzungen auf basis von aminosäuren und natriumhyaluronat ATE451916T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT002036A ITMI20052036A1 (it)	2005-10-26	2005-10-26	Composizioni farmaceutiche oftalmiche a base di amminoacidi e sodio ialuronato
PCT/EP2006/009967 WO2007048523A1 (en)	2005-10-26	2006-10-16	Ophthalmic pharmaceutical compositions based on amino acids and sodium hyaluronate

Publications (1)

Publication Number	Publication Date
ATE451916T1 true ATE451916T1 (de)	2010-01-15

Family

ID=37561156

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT06806304T ATE451916T1 (de)	2005-10-26	2006-10-16	Ophthalmische pharmazeutische zusammensetzungen auf basis von aminosäuren und natriumhyaluronat

Country Status (11)

Country	Link
US (2)	US20080249065A1 (de)
EP (1)	EP1940381B1 (de)
JP (1)	JP5312946B2 (de)
KR (1)	KR20080074107A (de)
AT (1)	ATE451916T1 (de)
CA (1)	CA2627215C (de)
DE (1)	DE602006011196D1 (de)
ES (1)	ES2335437T3 (de)
IT (1)	ITMI20052036A1 (de)
PL (1)	PL1940381T3 (de)
WO (1)	WO2007048523A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ITMI20052037A1 (it) *	2005-10-26	2007-04-27	Professional Dietetics Srl	Composizioni farmaceutiche cicatrizzanti sotto forma di polvere sterile a base di amminoacidi e sodio ialuronato
ITMI20052035A1 (it) *	2005-10-26	2007-04-27	Professional Dietetics Srl	Composizioni farmaceutiche cicatrizzanti sotto forma di crema a base di amminoacidi e sodio ialuronato
RU2540481C2 (ru) *	2009-07-27	2015-02-10	Сальваторе Троизи	Офтальмологический раствор для защиты внутренних структур глазного яблока от уф-а лучей или для лечения кератоконуса методом трансэпителиального кросс-линкинга
IT1396935B1 (it)	2009-11-26	2012-12-20	Solartium Entpr Ltd	Uso di una combinazione per il trattamento delle mucositi indotte da radiazioni o da chemioterapici
IT1397522B1 (it) *	2009-12-21	2013-01-16	Solartium Entpr Ltd	Uso di una combinazione per il trattamento dell'osteoartrosi
DE102010020940B4 (de) *	2010-05-19	2014-09-25	Heraeus Medical Gmbh	Antibiotische Beschichtung
CN104758921A (zh) *	2010-11-08	2015-07-08	希尔洛有限公司	缓冲的眼用组合物以及使用其的方法
AT511164A1 (de)	2011-03-03	2012-09-15	Croma Pharma Gmbh	Verwendung eines viskoelastischen fluids zur herstellung eines medizinproduktes für die chirurgische behandlung des auges
ITMI20110954A1 (it) *	2011-05-26	2012-11-27	Professional Dietetics Srl	Combinazioni per il trattamento delle mucositi vaginali o rettali
ES2604816B1 (es) *	2015-09-09	2018-01-29	Farmalider, S.A.	Composición farmacéutica de tramadol para uso oftálmico
IT201600116727A1 (it) *	2016-11-18	2018-05-18	Univ Politecnica Delle Marche	Composto per la guarigione di ferite
BR112021000724A2 (pt)	2018-07-27	2021-04-13	Johnson & Johnson Surgical Vision, Inc.	Composições e métodos para tratar os olhos
US10966948B2 (en)	2019-07-23	2021-04-06	Johnson & Johnson Surgical Vision, Inc.	Compositions and methods for treating the eye
US20200030226A1 (en)	2018-07-27	2020-01-30	Johnson & Johnson Consumer Inc.	Botanical and bacterial extracts displaying retinol-like activity
US11969454B2 (en)	2019-11-19	2024-04-30	Johnson & Johnson Surgical Vision, Inc.	Compositions and methods for treating the eye
WO2021170290A1 (en)	2020-02-28	2021-09-02	Immunologik Gmbh	Inhibitors of human deubiquitinases for the treatment of coronaviral infections
US20230165851A1 (en)	2020-04-27	2023-06-01	Immunologik Gmbh	6'-methoxycinchonan-9-ols for the treatment of coronaviral infections
AU2021288757B2 (en)	2020-06-10	2026-01-08	Metriopharm Ag	Compound for the treatment of coronaviral infections
EP3981405A1 (de)	2020-10-08	2022-04-13	MetrioPharm AG	Verbindung zur behandlung von coronavirusinfektionen
WO2022042873A1 (en)	2020-08-27	2022-03-03	Immunologik Gmbh	Pharmaceutically acceptable lectins derived from plants, fungi and bacteria for the treatment of sars-cov-2 infections
IT202100029726A1 (it)	2021-11-24	2023-05-24	Professional Dietetics Spa	Composizioni oftalmiche per il trattamento di lesioni corneali
EP4193994A1 (de)	2021-12-08	2023-06-14	MetrioPharm AG	Kombination von 5-amino-2,3-dihydro-1,4-phtalazinedion und einem 6'-methoxycinchonan-9-ol zur verwendung bei der behandlung von coronaviralen infektionen
EP4784132A1 (de)	2023-09-26	2026-08-05	MetrioPharm AG	5-amino-2,3-dihydro-1,4-phthalazindione zur behandlung von infektionen mit einem rna-virus

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6084225A (ja) *	1983-10-17	1985-05-13	Hiroko Shimizu	点眼剤
US4707354A (en) *	1985-06-17	1987-11-17	Alpen Tau, Inc.	Mature skin treatment and protectant compositions and methods of using same
JPH0723317B2 (ja) *	1988-03-17	1995-03-15	生化学工業株式会社	角膜上皮層障害症治療剤
JP3050898B2 (ja) *	1990-07-06	2000-06-12	千寿製薬株式会社	水性医薬製剤
WO1996003158A1 (en) *	1994-07-22	1996-02-08	Alcon Laboratories, Inc.	Use of low molecular weight amino acids in ophthalmic compositions
US6541460B2 (en) *	1996-08-07	2003-04-01	George D. Petito	Method for use of hyaluronic acid in wound management
JPH10290830A (ja) *	1997-04-18	1998-11-04	Ofutekusu:Kk	眼手術用補助剤
US6645948B2 (en)	1998-03-24	2003-11-11	George D. Petito	Nutritional composition for the treatment of connective tissue
US6620169B1 (en) *	1999-08-26	2003-09-16	Spineology Group, Llc.	Tools and method for processing and injecting bone graft
US6654948B1 (en) *	1999-10-12	2003-11-25	International Business Machines Corporation	Methods and apparatus for partial and consistent monitoring of object-oriented programs and systems
IT1318556B1 (it) *	2000-06-07	2003-08-27	Solartium Establishment	Composizione farmaceutica a base di prolina, glicina e lisina utilenella terapia per la cicatrizzazione delle ferite e delle lesioni
ITTO20010804A1 (it) *	2001-08-08	2003-02-08	Professional Dietetics Srl	Composizioni a base di aminoacidi, idonee alla terapia per la cicatrizzazione e/o riparazione di ferite e lesioni, in particolare per l'appl
US20040265268A1 (en) *	2001-08-18	2004-12-30	Deepak Jain	Compositions and methods for skin rejuvenation and repair
US6780841B2 (en) *	2001-11-13	2004-08-24	Biocell Technology, Llc	Hyaluronic acid and chondroitin sulfate based hydrolyzed collagen type II and method of making same
EP1379069A1 (de) *	2002-07-02	2004-01-07	Agfa-Gevaert AG	Vorrichtung und Verfahren zum Erfassen von Bildinformationen einer Bildvorlage
US20060094643A1 (en) *	2002-07-03	2006-05-04	Yuri Svirkin	Compositions of hyaluronic acid and methods of use
FR2849383B1 (fr) *	2002-12-26	2005-09-30	Jean Noel Thorel	Composition trophique en milieu aqueux, et ses applications, notamment en ophtalmologie
US20040180025A1 (en) *	2003-03-12	2004-09-16	New Life Resources, Llc	Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations
GB0404693D0 (en) *	2004-03-02	2004-04-07	Univ London	Pharmaceutical preparations for the treatment of ocular surface and other disorders
ITMI20052037A1 (it) *	2005-10-26	2007-04-27	Professional Dietetics Srl	Composizioni farmaceutiche cicatrizzanti sotto forma di polvere sterile a base di amminoacidi e sodio ialuronato
ITMI20052035A1 (it) *	2005-10-26	2007-04-27	Professional Dietetics Srl	Composizioni farmaceutiche cicatrizzanti sotto forma di crema a base di amminoacidi e sodio ialuronato

2005
- 2005-10-26 IT IT002036A patent/ITMI20052036A1/it unknown
2006
- 2006-10-16 JP JP2008536974A patent/JP5312946B2/ja not_active Expired - Fee Related
- 2006-10-16 CA CA2627215A patent/CA2627215C/en active Active
- 2006-10-16 KR KR1020087009861A patent/KR20080074107A/ko not_active Ceased
- 2006-10-16 EP EP06806304A patent/EP1940381B1/de active Active
- 2006-10-16 ES ES06806304T patent/ES2335437T3/es active Active
- 2006-10-16 AT AT06806304T patent/ATE451916T1/de not_active IP Right Cessation
- 2006-10-16 WO PCT/EP2006/009967 patent/WO2007048523A1/en not_active Ceased
- 2006-10-16 DE DE602006011196T patent/DE602006011196D1/de active Active
- 2006-10-16 US US12/091,481 patent/US20080249065A1/en not_active Abandoned
- 2006-10-16 PL PL06806304T patent/PL1940381T3/pl unknown
2010
- 2010-12-09 US US12/964,522 patent/US8524687B2/en active Active

Also Published As

Publication number	Publication date
CA2627215A1 (en)	2007-05-03
ITMI20052036A1 (it)	2007-04-27
CA2627215C (en)	2015-03-24
US8524687B2 (en)	2013-09-03
US20080249065A1 (en)	2008-10-09
JP5312946B2 (ja)	2013-10-09
JP2009513586A (ja)	2009-04-02
KR20080074107A (ko)	2008-08-12
EP1940381A1 (de)	2008-07-09
PL1940381T3 (pl)	2010-05-31
US20110077219A1 (en)	2011-03-31
WO2007048523A1 (en)	2007-05-03
EP1940381B1 (de)	2009-12-16
DE602006011196D1 (de)	2010-01-28
ES2335437T3 (es)	2010-03-26

Legal Events

Date	Code	Title	Description
2010-06-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
DE602006011196D1 (de)	2010-01-28	Ophthalmische pharmazeutische zusammensetzungen auf basis von aminosäuren und natriumhyaluronat
BRPI0809583A2 (pt)	2019-09-03	polipeptídeos fgf-21 modificados e seus usos
ATE451100T1 (de)	2009-12-15	Pharmazeutische wundheilungszusammensetzungen in form einer crome auf basis von aminosäuren und natriumhyaluronat
CY1118038T1 (el)	2017-05-17	Λυοφιλισμενες φαρμακοτεχνικες μορφες θεραπευτικου πεπτισωματος
CY1112682T1 (el)	2016-02-10	Ενεργες παραλλαγες της πρωτεϊνης προσδεσης il-18 και ιατρικες χρησεις αυτων
ATE489371T1 (de)	2010-12-15	Benzamidglucokinaseaktivatoren
UY30225A1 (es)	2007-10-31	Composiciones farmacéuticas
CY1115082T1 (el)	2016-12-14	Υποκατεστημενα παραγωγα 1,3-διφαινυλπροπανιου, παρασκευες και χρησεις αυτων
EP1991256A4 (de)	2010-09-15	Gerinnungs- und heilungszusammensetzungen mit keratinbiomaterial
NO20083245L (no)	2008-09-12	Sykliske antimikrobielle peptider
CL2007000161A1 (es)	2008-05-30	Compuestos derivados de 2,4-dioxoimidazolidina sustituida, inhibidores de proteinas cinasas; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer.
BR112012011332A2 (pt)	2016-11-22	agentes direcionados para gadd45beta
LTPA2019017I1 (lt)	2019-12-10	Oftalmologinės kompozicijos ir jų panaudojimas
DE602008002693D1 (de)	2010-11-04	Vakzine-peptid-kombinationen gegen katzenallergie
DE50306232D1 (de)	2007-02-15	Ampholytisches copolymer und dessen verwendung
BRPI0606403A2 (pt)	2009-06-23	formulações farmacêuticas com liberação sustentada e seus usos
LU92202I2 (fr)	2013-11-15	Aflibercept
ATE458746T1 (de)	2010-03-15	Melphalan-derivate und ihre verwendung als chemotherapeutika gegen krebs
CY1109537T1 (el)	2014-08-13	Πεπτιδια και παραγωγα πεπτιδιου, παρασκευη αυτων καθως επισης χρηση αυτων για την παρασκευη θεραπευτικως η/και προληπτικως δραστικης φαρμακευτικης συνθεσης
EP2154149A4 (de)	2011-04-06	Verkürztes l1-protein des humanen papillomavirus 6
EA201070484A1 (ru)	2011-04-29	Новые конъюгаты нейртурина для фармацевтического применения
ATE498413T1 (de)	2011-03-15	Pharmazeutische wundheilungs-zusammensetzungen in form eines sterilen pulvers auf basis von aminosäuren und natriumhyaluronat
BRPI0508596A (pt)	2007-08-21	combinação compreendendo ligante alfa-2-delta
BRPI0417205A (pt)	2007-02-06	composições farmacêuticas
ATE536368T1 (de)	2011-12-15	Konjugate von zytotoxischen verbindungen mit peptiden